Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility and safety of treating malunion distal radius with corrective osteotomy plus bone marrow-derived mesenchymal stem cells and hydroxyapatite
TCTR20220124001Phase 1Completed
- Sponsor
- Ramathibodi Hospital Department of Orthopedics
- Start
- Jan 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bone marrow-derived mesenchymal stem cells in distal radius fracture malunion (DRFM), sponsored by Ramathibodi Hospital Department of Orthopedics. Started Jan 2022; status: completed.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
distal radius fracture malunion (DRFM)
Beyond the preview
Go deeper on TCTR20220124001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220124001.